Search for: "GLOBAL BIOTECHNOLOGIES INC"
Results 1 - 20
of 151
Sorted by Relevance
|
Sort by Date
8 Jun 2012, 12:40 pm
Marshalls recently seized several drug products from Maine-based Global Biotechnologies, Inc. due to violations of the FDA’s Food, Drug and Cosmetic Act. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
25 Sep 2015, 6:45 am
MBBP client, Selvita, recently announced an expansion into the Boston-area biotechnology and pharmaceutical market, as they open a fully-owned US subsidiary, Selvita Inc., headquartered in Cambridge, Massachusetts. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
2 Aug 2022, 10:00 pm
Biogen Inc., a global biotechnology company, denies that it violated the federal Anti-Kickback Statute and False Claims Act by paying healthcare professionals for fraudulent speaking engagements in order to incentivize them to prescribe the company’s drugs, among other allegations stemming from a whistleblower suit. [read post]
5 Oct 2009, 9:00 am
PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. [read post]
19 Dec 2012, 9:47 pm
District Judge Sterling Johnson, Jr. accepted a guilty plea by American biotechnology giant Amgen Inc. [read post]
16 Jun 2012, 5:48 am
The event will be featured at the 2012 BIO International Convention, the global event for biotechnology, taking place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA. [read post]
1 Sep 2020, 9:10 am
The problem with pharmaceutical and biotechnology investments such as Miramar Labs Inc. is that they typically involve a high degree of risk. [read post]
8 Feb 2017, 9:33 am
Myriad Genetics, Inc. and Alice Corp. v. [read post]
14 Jul 2009, 4:31 pm
Exxon is joining Synthetic Genomics Inc., a biotechnology company founded by the genomics pioneer J. [read post]
10 Feb 2009, 9:39 am
This focuses on the example of an agreement between the United States National Park Service and Diversa Inc (now Verenium) in relation to bioprospecting in Yellowstone National Park. [read post]
13 Jun 2012, 6:22 pm
Hosted by the Biotechnology Industry Organization(BIO), this year’s global event for biotechnology will take place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA. [read post]
23 Jun 2010, 10:28 pm
(Patent Baristas) Biotechnology management papers 2010 (Biotech Blog) (Biotech Blog) Nanofutures - the future of Nanotechnology IP? [read post]
15 Oct 2021, 4:04 am
[Answer in first comment].In re Quantgene Inc., Serial No. 88720359 (October 12, 2021) [not precedential] (Opinion by Judge Robert H. [read post]
19 May 2010, 6:15 am
Immutopics, Inc. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
